The startup aims to revolutionise how neurological rehabilitation is delivered to drive better outcomes and recovery for patients.
Neurofenix has raised €7.0M across 1 funding round from 3 investors, most recently a Series A round in Aug 2022. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-08-30 | Series A | €7.0M |
| AlbionVC,HTH,InHealth Ventures |
| View deal → |
